This edited volume is a definitive text on adaptive clinical
trial designs from creation and customization to utilization. As
this book covers the full spectrum of topics involved in the
adaptive designs arena, it will serve as a valuable reference for
researchers working in industry, government and academia. The
target audience is anyone involved in the planning and execution of
clinical trials, in particular, statisticians, clinicians,
pharmacometricians, clinical operation specialists, drug supply
managers, and infrastructure providers. In spite of the increased
efficiency of adaptive trials in saving costs and time, ultimately
getting drugs to patients sooner, their adoption in clinical
development is still relatively low. One of the chief reasons is
the higher complexity of adaptive design trials as compared to
traditional trials. Barriers to the use of clinical trials with
adaptive features include the concerns about the integrity of study
design and conduct, the risk of regulatory non-acceptance, the need
for an advanced infrastructure for complex randomization and
clinical supply scenarios, change management for process and
behavior modifications, extensive resource requirements for the
planning and design of adaptive trials and the potential to
relegate key decision makings to outside entities. There have been
limited publications that address these practical considerations
and recommend best practices and solutions. This book fills this
publication gap, providing guidance on practical considerations for
adaptive trial design and implementation. The book comprises three
parts: Part I focuses on practical considerations from a design
perspective, whereas Part II delineates practical considerations
related to the implementation of adaptive trials. Putting it all
together, Part III presents four illustrative case studies ranging
from description and discussion of specific adaptive trial design
considerations to the logistic and regulatory issues faced in trial
implementation.
Bringing together the expertise of leading key opinion leaders
from pharmaceutical industry, academia, and regulatory agencies,
this book provides a balanced and comprehensive coverage of
practical considerations for adaptive trial design and
implementation.
General
Is the information for this product incomplete, wrong or inappropriate?
Let us know about it.
Does this product have an incorrect or missing image?
Send us a new image.
Is this product missing categories?
Add more categories.
Review This Product
No reviews yet - be the first to create one!